Consortium for Technology and Innovation in Pediatrics
CTIP - The Southern California pediatric medical device consortium

  • Unique Teams
  • For Unique Needs
  • To Bring Novel Devices to Benefit the Lives of Children
Supporting pediatric
innovation today.

Developing the pediatric innovators of tomorrow.


As healthcare continues along its perpetual evolution, those in the industry are continually trying to get ahead of the curve and find solutions to the biggest issues facing patient care and delivery today. Some hospitals and health systems have made a commitment to innovation by establishing their own centers and institutes for innovation.

On Wednesday, August 26th 2015, the National Institutes of Health (NIH) announced the release of its revised Priority List of Needs in Pediatric Therapeutics for 2015. The Best Pharmaceuticals for Children Act of 2002 requires that the NIH, in consultation with the Food and Drug Administration and experts in pediatric research, identify the drugs and therapeutic areas of highest priority for study in pediatric populations. The list is organized by therapeutic area, which can be a group of conditions, a subgroup of the population, or a setting of care. BPCA legislation requires the NIH to update the priority list every three years. To view the Federal Register Notice and background: To view the 2015 Priority List of Needs in Pediatric Therapeutics:

Medulloblastoma, the most commonly occurring malignant brain tumor in children, can be classified into four subgroups—each with a different risk profile requiring subgroup-specific therapy. Currently, subgroup determination is done after...

There's a serious need for pediatric medical devices - but little innovation in this market. The Sheikh Zayed Institute is working to change that.